Abstract:Background and ethnopharmacological relevance Semen aesculi (SA), a traditional Chinese herb, has been used in the treatment of gastrointestinal disease for thousands of years. The escin was the main components of SA. A growing number of research showed that escin has a wide range of pharmacological activities in intestinal barrier dysfunction. Aim of the study Inflammatory bowel diseases (IBD) are an idiopathic disease of the intestinal tract with the hallmark features of mucosal inflammation and loss of barrier function. The theory of traditional Chinese medicine (TCM) suggests that SA plays a potential role in protecting the gastrointestinal diseases. The present study aimed to explore the effects of SA on the intestinal barrier under existing inflammatory conditions and elucidate underlying mechanisms. Materials and methods The bioactive components of SA and their predicted biological targets were combined to develop a compound target pathway network. It is used to predict the bioactive components, molecular targets, and molecular pathways of SA in improving IBD. The ingredients of SA were extracted by decoction either in water and ethanol and separated into four fractions (AE, EE, PEE and PCE). The effects of extractions were evaluated in the lipopolysaccharide (LPS)-induced RAW264.7 macrophages cell model, LPS-induced intestinal barrier injury model and imodium-induced constipation model. The high-performance liquid chromatography (HPLC) analysis was performed to identify the bioactive components. Results The compound-target pathway network was identified with 10 bioactive compounds, 166 IBD-related targets, and 52 IBD-related pathways. In LPS-induced RAW264.7 cells, PEE and PCE significantly decreased nitric oxide (NO) production and TNF-α level. In mice, PEE and PCE administration improved intestinal barrier damage, increased intestinal motility, reduced levels of TNF-α and diamine oxidase (DAO). Furthermore, PEE and PCE administration not only decreased expression of p-Akt, p-IκBα, nuclear p-p65, and TNF-α level, but also increased expression of the zonula occludin-1 (ZO-1) in LPS-induced intestinal barrier injury model. The escin content of AE, EE, PEE and PCE gradually increased with an increase of the bioactivity. Conclusions Escin was the main bioactive components of SA. The effects of SA on IBD were mediated by repairing the intestinal barrier and promoting intestinal motility. The mechanism of action of SA is related to inhibiting the Akt/NF-κB signaling pathway in intestinal tissue, at least, in part. Our results provide a scientific basis for further exploring the mechanisms involved in the beneficial effects of SA in IBD.

Studies on the biotransformation of escin Ia by human intestinal bacteria and the anti-tumor activities of desacylescin Ⅰ

Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

β-Escin: An Updated Review of Its Analysis, Pharmacology, Pharmacokinetics, and Toxicity

Beta-aescin: A Potent Natural Inhibitor of Proliferation and Inducer of Apoptosis in Human Chronic Myeloid Leukemia K562 Cells in Vitro

Computational and experimental characterization of isomers of escin-induced renal cytotoxicity by inhibiting heat shock proteins

Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.

Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiota

Pharmacological and Therapeutic Applications of Esculetin

Naturally Occurring Aesculetin Coumarin Exerts Antiproliferative Effects in Gastric Cancer Cells Mediated Via Apoptotic Cell Death, Cell Cycle Arrest and Targeting PI3K/AKT/M-TOR Signalling Pathway.

Esculetin Induces Apoptosis in Human Gastric Cancer Cells Through a Cyclophilin D-mediated Mitochondrial Permeability Transition Pore Associated with ROS.

Role of Escin in Breast Cancer Therapy: Potential Mechanism for Inducing Ferroptosis and Synergistic Antitumor Activity with Cisplatin

Escin's Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review

Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis

The pharmacological and pharmacokinetic properties of esculin: A comprehensive review

Therapeutic potential of esculetin in various cancer types (Review)

Ardipusilloside-I Metabolites from Human Intestinal Bacteria and Their Antitumor Activity

Improvement effects of esculetin on the formation and development of atherosclerosis

Effect of ethyl pyruvate on human esophageal squamous cell carcinoma transplanted tumors in nude mice

Integrated systematic pharmacology analysis and experimental validation to reveal the mechanism of action of Semen aesculi on inflammatory bowel diseases

Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC